nodes	percent_of_prediction	percent_of_DWPC	metapath
Astemizole—CYP2D6—Parkinson's disease	0.499	0.583	CbGaD
Astemizole—ABCB1—Parkinson's disease	0.356	0.417	CbGaD
Astemizole—Fluspirilene—HTR1A—Parkinson's disease	0.00123	0.134	CrCbGaD
Astemizole—Pimozide—DRD3—Parkinson's disease	0.00113	0.123	CrCbGaD
Astemizole—Fluspirilene—DRD2—Parkinson's disease	0.00104	0.114	CrCbGaD
Astemizole—CYP2J2—forebrain—Parkinson's disease	0.000983	0.0736	CbGeAlD
Astemizole—Pimozide—HTR1A—Parkinson's disease	0.000918	0.101	CrCbGaD
Astemizole—CYP2J2—cardiovascular system—Parkinson's disease	0.000831	0.0622	CbGeAlD
Astemizole—Fluspirilene—HTR2A—Parkinson's disease	0.000806	0.0882	CrCbGaD
Astemizole—Pimozide—DRD2—Parkinson's disease	0.000779	0.0853	CrCbGaD
Astemizole—Pimozide—CYP2E1—Parkinson's disease	0.00075	0.0821	CrCbGaD
Astemizole—CYP2J2—medulla oblongata—Parkinson's disease	0.00071	0.0532	CbGeAlD
Astemizole—CYP2J2—midbrain—Parkinson's disease	0.000649	0.0486	CbGeAlD
Astemizole—CYP2J2—spinal cord—Parkinson's disease	0.000633	0.0474	CbGeAlD
Astemizole—Pimozide—HTR2A—Parkinson's disease	0.000602	0.0659	CrCbGaD
Astemizole—Flunarizine—CYP2D6—Parkinson's disease	0.000597	0.0654	CrCbGaD
Astemizole—CYP2J2—head—Parkinson's disease	0.000563	0.0421	CbGeAlD
Astemizole—Pimozide—CYP2D6—Parkinson's disease	0.000551	0.0603	CrCbGaD
Astemizole—CYP2J2—nervous system—Parkinson's disease	0.000534	0.04	CbGeAlD
Astemizole—CYP2J2—central nervous system—Parkinson's disease	0.000514	0.0385	CbGeAlD
Astemizole—CYP2J2—cerebellum—Parkinson's disease	0.000502	0.0376	CbGeAlD
Astemizole—CYP2D6—hindbrain—Parkinson's disease	0.000462	0.0346	CbGeAlD
Astemizole—KCNH2—forebrain—Parkinson's disease	0.000419	0.0314	CbGeAlD
Astemizole—CYP2J2—brain—Parkinson's disease	0.000408	0.0305	CbGeAlD
Astemizole—Pimozide—ABCB1—Parkinson's disease	0.000393	0.0431	CrCbGaD
Astemizole—KCNH2—cardiovascular system—Parkinson's disease	0.000354	0.0265	CbGeAlD
Astemizole—Fentanyl—ABCB1—Parkinson's disease	0.000341	0.0373	CrCbGaD
Astemizole—HRH1—forebrain—Parkinson's disease	0.000336	0.0251	CbGeAlD
Astemizole—KCNH2—medulla oblongata—Parkinson's disease	0.000303	0.0227	CbGeAlD
Astemizole—KCNH2—midbrain—Parkinson's disease	0.000277	0.0207	CbGeAlD
Astemizole—KCNH2—spinal cord—Parkinson's disease	0.00027	0.0202	CbGeAlD
Astemizole—CYP2D6—brainstem—Parkinson's disease	0.000265	0.0198	CbGeAlD
Astemizole—CYP2D6—forebrain—Parkinson's disease	0.000256	0.0191	CbGeAlD
Astemizole—KCNH2—head—Parkinson's disease	0.00024	0.018	CbGeAlD
Astemizole—KCNH2—nervous system—Parkinson's disease	0.000228	0.017	CbGeAlD
Astemizole—KCNH2—central nervous system—Parkinson's disease	0.000219	0.0164	CbGeAlD
Astemizole—KCNH2—cerebellum—Parkinson's disease	0.000214	0.016	CbGeAlD
Astemizole—ABCB1—embryo—Parkinson's disease	0.000208	0.0156	CbGeAlD
Astemizole—HRH1—head—Parkinson's disease	0.000192	0.0144	CbGeAlD
Astemizole—ABCB1—forebrain—Parkinson's disease	0.000184	0.0138	CbGeAlD
Astemizole—HRH1—nervous system—Parkinson's disease	0.000182	0.0137	CbGeAlD
Astemizole—HRH1—central nervous system—Parkinson's disease	0.000176	0.0131	CbGeAlD
Astemizole—KCNH2—brain—Parkinson's disease	0.000174	0.013	CbGeAlD
Astemizole—ABCB1—cardiovascular system—Parkinson's disease	0.000155	0.0116	CbGeAlD
Astemizole—CYP2D6—head—Parkinson's disease	0.000146	0.011	CbGeAlD
Astemizole—CYP3A4—nervous system—Parkinson's disease	0.000141	0.0106	CbGeAlD
Astemizole—HRH1—brain—Parkinson's disease	0.000139	0.0104	CbGeAlD
Astemizole—CYP2D6—nervous system—Parkinson's disease	0.000139	0.0104	CbGeAlD
Astemizole—CYP3A4—central nervous system—Parkinson's disease	0.000136	0.0102	CbGeAlD
Astemizole—CYP2D6—central nervous system—Parkinson's disease	0.000134	0.01	CbGeAlD
Astemizole—ABCB1—medulla oblongata—Parkinson's disease	0.000133	0.00994	CbGeAlD
Astemizole—CYP2D6—cerebellum—Parkinson's disease	0.000131	0.00977	CbGeAlD
Astemizole—ABCB1—midbrain—Parkinson's disease	0.000121	0.00909	CbGeAlD
Astemizole—ABCB1—spinal cord—Parkinson's disease	0.000118	0.00887	CbGeAlD
Astemizole—CYP2D6—brain—Parkinson's disease	0.000106	0.00794	CbGeAlD
Astemizole—ABCB1—head—Parkinson's disease	0.000105	0.00788	CbGeAlD
Astemizole—ABCB1—nervous system—Parkinson's disease	9.98e-05	0.00747	CbGeAlD
Astemizole—ABCB1—central nervous system—Parkinson's disease	9.61e-05	0.00719	CbGeAlD
Astemizole—ABCB1—cerebellum—Parkinson's disease	9.39e-05	0.00703	CbGeAlD
Astemizole—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	8.47e-05	0.000693	CbGpPWpGaD
Astemizole—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	8.45e-05	0.000692	CbGpPWpGaD
Astemizole—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	8.39e-05	0.000687	CbGpPWpGaD
Astemizole—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	8.38e-05	0.000686	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—VPS35—Parkinson's disease	8.35e-05	0.000684	CbGpPWpGaD
Astemizole—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	8.35e-05	0.000684	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—TH—Parkinson's disease	8.35e-05	0.000684	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—PENK—Parkinson's disease	8.31e-05	0.000681	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	8.21e-05	0.000672	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—GBA—Parkinson's disease	8.13e-05	0.000666	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—DBH—Parkinson's disease	8.13e-05	0.000666	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—FBP1—Parkinson's disease	8.13e-05	0.000666	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	8.08e-05	0.000661	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	8.07e-05	0.000661	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	8.05e-05	0.000659	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	8.04e-05	0.000659	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—CYCS—Parkinson's disease	8.02e-05	0.000656	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—GRM4—Parkinson's disease	7.96e-05	0.000652	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	7.95e-05	0.000651	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—HTR7—Parkinson's disease	7.81e-05	0.000639	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—DRD2—Parkinson's disease	7.81e-05	0.000639	CbGpPWpGaD
Astemizole—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	7.78e-05	0.000637	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—ND3—Parkinson's disease	7.76e-05	0.000635	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—MCCC1—Parkinson's disease	7.76e-05	0.000635	CbGpPWpGaD
Astemizole—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	7.67e-05	0.000628	CbGpPWpGaD
Astemizole—ABCB1—brain—Parkinson's disease	7.63e-05	0.00571	CbGeAlD
Astemizole—HRH1—GPCR downstream signaling—PDYN—Parkinson's disease	7.6e-05	0.000623	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—PENK—Parkinson's disease	7.55e-05	0.000618	CbGpPWpGaD
Astemizole—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	7.34e-05	0.000601	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—TALDO1—Parkinson's disease	7.29e-05	0.000597	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—OMD—Parkinson's disease	7.29e-05	0.000597	CbGpPWpGaD
Astemizole—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	7.24e-05	0.000593	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	7.18e-05	0.000588	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—COMT—Parkinson's disease	7.1e-05	0.000581	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—GRM5—Parkinson's disease	7.07e-05	0.000579	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—GSTP1—Parkinson's disease	7.07e-05	0.000579	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	7.06e-05	0.000578	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—MAOA—Parkinson's disease	7.05e-05	0.000577	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—HMOX1—Parkinson's disease	6.97e-05	0.000571	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—GPR37—Parkinson's disease	6.92e-05	0.000567	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—DGKQ—Parkinson's disease	6.92e-05	0.000567	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—NDUFB11—Parkinson's disease	6.92e-05	0.000566	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—PDYN—Parkinson's disease	6.9e-05	0.000565	CbGpPWpGaD
Astemizole—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	6.71e-05	0.00055	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—ABCB1—Parkinson's disease	6.69e-05	0.000548	CbGpPWpGaD
Astemizole—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	6.62e-05	0.000542	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—GCH1—Parkinson's disease	6.6e-05	0.00054	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—GSTM1—Parkinson's disease	6.49e-05	0.000532	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—GRM5—Parkinson's disease	6.42e-05	0.000526	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PPP1R1B—Parkinson's disease	6.33e-05	0.000518	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—EDN1—Parkinson's disease	6.25e-05	0.000512	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—GPX1—Parkinson's disease	6.22e-05	0.000509	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—ADORA2A—Parkinson's disease	6.01e-05	0.000492	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—DDC—Parkinson's disease	5.97e-05	0.000489	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5.91e-05	0.000484	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—FBP1—Parkinson's disease	5.88e-05	0.000481	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—DBH—Parkinson's disease	5.88e-05	0.000481	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—GBA—Parkinson's disease	5.88e-05	0.000481	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—TNF—Parkinson's disease	5.86e-05	0.00048	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—ND3—Parkinson's disease	5.85e-05	0.000479	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—MCCC1—Parkinson's disease	5.85e-05	0.000479	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—MTHFR—Parkinson's disease	5.74e-05	0.00047	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—GSTA4—Parkinson's disease	5.64e-05	0.000462	CbGpPWpGaD
Astemizole—CYP3A4—Biological oxidations—COMT—Parkinson's disease	5.56e-05	0.000455	CbGpPWpGaD
Astemizole—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	5.54e-05	0.000453	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—RIT2—Parkinson's disease	5.53e-05	0.000453	CbGpPWpGaD
Astemizole—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	5.52e-05	0.000452	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—ND3—Parkinson's disease	5.52e-05	0.000452	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—MCCC1—Parkinson's disease	5.52e-05	0.000452	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—OMD—Parkinson's disease	5.5e-05	0.000451	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—TALDO1—Parkinson's disease	5.5e-05	0.000451	CbGpPWpGaD
Astemizole—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	5.49e-05	0.000449	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—HTR2A—Parkinson's disease	5.47e-05	0.000448	CbGpPWpGaD
Astemizole—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	5.46e-05	0.000447	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—ADORA2A—Parkinson's disease	5.46e-05	0.000447	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	5.44e-05	0.000446	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—APOE—Parkinson's disease	5.34e-05	0.000437	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—GRK5—Parkinson's disease	5.24e-05	0.000429	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—NDUFB11—Parkinson's disease	5.22e-05	0.000427	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—HTR1A—Parkinson's disease	5.22e-05	0.000427	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—OMD—Parkinson's disease	5.19e-05	0.000425	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—TALDO1—Parkinson's disease	5.19e-05	0.000425	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—TAC1—Parkinson's disease	5.14e-05	0.000421	CbGpPWpGaD
Astemizole—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	5.09e-05	0.000417	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PLA2G6—Parkinson's disease	5.08e-05	0.000416	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—DRD1—Parkinson's disease	5.04e-05	0.000412	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—MAOB—Parkinson's disease	5.03e-05	0.000411	CbGpPWpGaD
Astemizole—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	5.02e-05	0.000411	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—GCH1—Parkinson's disease	4.98e-05	0.000408	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	4.92e-05	0.000403	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—DRD3—Parkinson's disease	4.88e-05	0.000399	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—HTR1A—Parkinson's disease	4.74e-05	0.000388	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—GRM4—Parkinson's disease	4.7e-05	0.000385	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—GCH1—Parkinson's disease	4.69e-05	0.000384	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—TAC1—Parkinson's disease	4.66e-05	0.000382	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—DRD1—Parkinson's disease	4.57e-05	0.000375	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—INS—Parkinson's disease	4.56e-05	0.000374	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—ADRBK1—Parkinson's disease	4.55e-05	0.000373	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PENK—Parkinson's disease	4.46e-05	0.000365	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—MAG—Parkinson's disease	4.46e-05	0.000365	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—GBA—Parkinson's disease	4.44e-05	0.000363	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—FBP1—Parkinson's disease	4.44e-05	0.000363	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—DBH—Parkinson's disease	4.44e-05	0.000363	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—DRD3—Parkinson's disease	4.43e-05	0.000363	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—DRD2—Parkinson's disease	4.41e-05	0.000361	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—HTR7—Parkinson's disease	4.41e-05	0.000361	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—DDC—Parkinson's disease	4.32e-05	0.000353	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—FBP1—Parkinson's disease	4.18e-05	0.000342	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—GBA—Parkinson's disease	4.18e-05	0.000342	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—DBH—Parkinson's disease	4.18e-05	0.000342	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—ADRBK1—Parkinson's disease	4.14e-05	0.000339	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PDYN—Parkinson's disease	4.08e-05	0.000334	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—GSTA4—Parkinson's disease	4.08e-05	0.000334	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—DRD2—Parkinson's disease	4.01e-05	0.000328	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—HTR7—Parkinson's disease	4.01e-05	0.000328	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	3.97e-05	0.000325	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.88e-05	0.000317	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—GFAP—Parkinson's disease	3.83e-05	0.000314	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—GRM5—Parkinson's disease	3.79e-05	0.00031	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—CYP2D6—Parkinson's disease	3.73e-05	0.000306	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.72e-05	0.000305	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PLA2G6—Parkinson's disease	3.67e-05	0.0003	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—CTGF—Parkinson's disease	3.67e-05	0.0003	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	3.65e-05	0.000299	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—MAOB—Parkinson's disease	3.63e-05	0.000297	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—MCCC1—Parkinson's disease	3.61e-05	0.000295	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—ND3—Parkinson's disease	3.61e-05	0.000295	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—EDN1—Parkinson's disease	3.53e-05	0.000289	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—CYP2E1—Parkinson's disease	3.42e-05	0.00028	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—TALDO1—Parkinson's disease	3.39e-05	0.000278	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—OMD—Parkinson's disease	3.39e-05	0.000278	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—NQO1—Parkinson's disease	3.38e-05	0.000277	CbGpPWpGaD
Astemizole—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	3.36e-05	0.000276	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—TH—Parkinson's disease	3.33e-05	0.000273	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—FGF20—Parkinson's disease	3.32e-05	0.000272	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—DDC—Parkinson's disease	3.26e-05	0.000267	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.24e-05	0.000265	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—ADORA2A—Parkinson's disease	3.22e-05	0.000264	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	3.21e-05	0.000263	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—EDN1—Parkinson's disease	3.21e-05	0.000263	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—CYCS—Parkinson's disease	3.2e-05	0.000262	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—HTR2A—Parkinson's disease	3.09e-05	0.000253	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—GSTA4—Parkinson's disease	3.08e-05	0.000252	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—DDC—Parkinson's disease	3.07e-05	0.000251	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GCH1—Parkinson's disease	3.07e-05	0.000251	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—INSR—Parkinson's disease	2.98e-05	0.000244	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—GSTA4—Parkinson's disease	2.9e-05	0.000237	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	2.89e-05	0.000237	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—COMT—Parkinson's disease	2.83e-05	0.000232	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—GSTP1—Parkinson's disease	2.82e-05	0.000231	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—FGB—Parkinson's disease	2.81e-05	0.00023	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—MAOA—Parkinson's disease	2.81e-05	0.00023	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—HTR2A—Parkinson's disease	2.81e-05	0.00023	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—HTR1A—Parkinson's disease	2.8e-05	0.000229	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—HMOX1—Parkinson's disease	2.78e-05	0.000227	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PLA2G6—Parkinson's disease	2.77e-05	0.000227	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—TAC1—Parkinson's disease	2.76e-05	0.000226	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—MAOB—Parkinson's disease	2.74e-05	0.000224	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GBA—Parkinson's disease	2.73e-05	0.000224	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—FBP1—Parkinson's disease	2.73e-05	0.000224	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—DBH—Parkinson's disease	2.73e-05	0.000224	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—DRD1—Parkinson's disease	2.7e-05	0.000221	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CYP2D6—Parkinson's disease	2.7e-05	0.000221	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—ABCB1—Parkinson's disease	2.67e-05	0.000218	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CTGF—Parkinson's disease	2.65e-05	0.000217	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—DRD3—Parkinson's disease	2.62e-05	0.000214	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	2.61e-05	0.000214	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—GSTM1—Parkinson's disease	2.59e-05	0.000212	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—MAOB—Parkinson's disease	2.58e-05	0.000212	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—GPX1—Parkinson's disease	2.48e-05	0.000203	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CYP2E1—Parkinson's disease	2.47e-05	0.000202	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	2.44e-05	0.0002	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—NQO1—Parkinson's disease	2.44e-05	0.0002	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—TH—Parkinson's disease	2.41e-05	0.000197	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—HTR7—Parkinson's disease	2.37e-05	0.000194	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—DRD2—Parkinson's disease	2.37e-05	0.000194	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CYCS—Parkinson's disease	2.31e-05	0.000189	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—MTHFR—Parkinson's disease	2.29e-05	0.000187	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—APOE—Parkinson's disease	2.13e-05	0.000174	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—COMT—Parkinson's disease	2.05e-05	0.000168	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CYP2D6—Parkinson's disease	2.04e-05	0.000167	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—GSTP1—Parkinson's disease	2.04e-05	0.000167	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—MAOA—Parkinson's disease	2.03e-05	0.000166	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—HMOX1—Parkinson's disease	2.01e-05	0.000164	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—DDC—Parkinson's disease	2.01e-05	0.000164	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CTGF—Parkinson's disease	2e-05	0.000164	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—IGF2—Parkinson's disease	1.98e-05	0.000162	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—ABCB1—Parkinson's disease	1.93e-05	0.000158	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	1.92e-05	0.000157	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.89e-05	0.000155	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—EDN1—Parkinson's disease	1.89e-05	0.000155	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.88e-05	0.000154	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—GSTM1—Parkinson's disease	1.87e-05	0.000153	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CYP2E1—Parkinson's disease	1.86e-05	0.000153	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—NQO1—Parkinson's disease	1.84e-05	0.000151	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—INS—Parkinson's disease	1.82e-05	0.000149	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—TH—Parkinson's disease	1.82e-05	0.000149	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—GPX1—Parkinson's disease	1.79e-05	0.000147	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.76e-05	0.000144	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CYCS—Parkinson's disease	1.74e-05	0.000143	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—NGF—Parkinson's disease	1.74e-05	0.000143	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.74e-05	0.000142	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—TH—Parkinson's disease	1.71e-05	0.00014	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.71e-05	0.00014	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.69e-05	0.000138	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	1.66e-05	0.000136	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—MTHFR—Parkinson's disease	1.65e-05	0.000135	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.64e-05	0.000135	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—COMT—Parkinson's disease	1.54e-05	0.000126	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—APOE—Parkinson's disease	1.54e-05	0.000126	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—APOE—Parkinson's disease	1.54e-05	0.000126	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—GSTP1—Parkinson's disease	1.54e-05	0.000126	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—MAOA—Parkinson's disease	1.53e-05	0.000126	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—HMOX1—Parkinson's disease	1.52e-05	0.000124	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—COMT—Parkinson's disease	1.45e-05	0.000119	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.45e-05	0.000119	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.44e-05	0.000118	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.43e-05	0.000117	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—GSTM1—Parkinson's disease	1.41e-05	0.000116	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.37e-05	0.000112	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—GPX1—Parkinson's disease	1.35e-05	0.000111	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.33e-05	0.000109	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—INS—Parkinson's disease	1.32e-05	0.000108	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—INS—Parkinson's disease	1.32e-05	0.000108	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.27e-05	0.000104	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.26e-05	0.000103	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—MTHFR—Parkinson's disease	1.25e-05	0.000102	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.23e-05	0.000101	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.18e-05	9.63e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—APOE—Parkinson's disease	1.16e-05	9.51e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.15e-05	9.4e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.14e-05	9.29e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—TH—Parkinson's disease	1.12e-05	9.16e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—APOE—Parkinson's disease	1.09e-05	8.96e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.07e-05	8.79e-05	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—INS—Parkinson's disease	9.93e-06	8.13e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CASP3—Parkinson's disease	9.8e-06	8.03e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—IL6—Parkinson's disease	9.74e-06	7.97e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—COMT—Parkinson's disease	9.51e-06	7.79e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GSTP1—Parkinson's disease	9.47e-06	7.75e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—MAOA—Parkinson's disease	9.44e-06	7.73e-05	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—INS—Parkinson's disease	9.35e-06	7.66e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—HMOX1—Parkinson's disease	9.34e-06	7.65e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	9.01e-06	7.38e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—ABCB1—Parkinson's disease	8.96e-06	7.34e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GSTM1—Parkinson's disease	8.7e-06	7.12e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GPX1—Parkinson's disease	8.33e-06	6.82e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—MTHFR—Parkinson's disease	7.69e-06	6.3e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—APOE—Parkinson's disease	7.16e-06	5.86e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—INS—Parkinson's disease	6.11e-06	5.01e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—IL6—Parkinson's disease	5.75e-06	4.71e-05	CbGpPWpGaD
